Search

Your search keyword '"Morishita, E."' showing total 264 results

Search Constraints

Start Over You searched for: Author "Morishita, E." Remove constraint Author: "Morishita, E."
264 results on '"Morishita, E."'

Search Results

51. A novel factor V compound heterozygous mutation associated with thrombosis (Y1961C; FV-Kanazawa, together with 1982_1983del).

52. Platelet and large platelet ratios are useful in predicting severity of COVID-19.

53. Thrombosis-related characteristics of pregnant women with antithrombin deficiency, protein C deficiency and protein S deficiency in Japan.

54. Relapse of Acquired Hemophilia A after COVID-19 Infection.

55. Identification of two de novo variants causing inherited antithrombin deficiency by quantitative analysis of variant alleles.

56. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023.

57. Functional analysis of two abnormal antithrombin proteins with different intracellular kinetics.

58. Moving against thrombosis: ISTH recognizes 10th anniversary of World Thrombosis Day and the leaders in the field who led the way - in memory of Claire McLintock, MD, World Thrombosis Day Steering Committee Vice Chair 2019 to 2022.

59. Protein S deficiency caused by cryptic splicing due to the novel intron variant c.346+5G>C in PROS1.

60. Biosynthetic diversification of non-ribosomal peptides through activity-based protein profiling of adenylation domains.

61. The length of the sanitary napkins can be used as a handier index than pictorial blood loss assessment chart to predict the heavy menstrual bleeding.

62. Identification and functional analysis of three novel genetic variants resulting in premature termination codons in three unrelated patients with hereditary antithrombin deficiency.

63. Effect of Anticoagulant/Antifibrinolytic Combination Therapy on Enhanced Fibrinolytic-Type Disseminated Intravascular Coagulation in End-of-Life Stage Solid Tumor Patients.

64. Factor V Leiden-independent activated protein C resistance: Communication from the plasma coagulation inhibitors subcommittee of the International Society on Thrombosis and Haemostasis Scientific and Standardisation Committee.

65. Computational analyses reveal fundamental properties of the AT structure related to thrombosis.

66. Time of Day of Vaccination Does Not Associate With SARS-CoV-2 Antibody Titer Following First Dose of mRNA COVID-19 Vaccine.

68. Peripartum management of hereditary thrombophilia: results of primary surveillance in Japan.

69. A case of venous thromboembolism caused by protein C deficiency due to a novel gene mutation.

70. Effect on Plasma Protein S Activity in Patients Receiving the Factor Xa Inhibitors.

71. [Thrombosis with Thrombocytopenia Syndrome after ChAdOx1 nCoV-19 vaccination].

72. Determination of diagnostic threshold in harmonization and comparison of clinical utility for five major antiphospholipid antibody assays used in Japan.

73. Recombinant human erythropoietin attenuates hepatic dysfunction by suppressing hepatocellular apoptosis in lipopolysaccharide-induced disseminated intravascular coagulation in rats.

75. COVID-19 and Thrombosis: Clinical Aspects.

77. Blue Rubber Bleb Nevus Syndrome Complicated by Enhanced-Fibrinolytic-Type DIC: A Case Report.

78. Clinical guidance for peripartum management of patients with hereditary thrombophilia.

79. Detailed exploration of pathophysiology involving inflammatory status and bleeding symptoms between lipopolysaccharide- and tissue factor-induced disseminated intravascular coagulation in rats.

80. Effect of NOS Inhibitors and Anticoagulants on Nitric Oxide Production in a Tissue-factor Induced Rat DIC Model.

81. A Case of Treatment With Dabigatran for Cerebral Venous Thrombosis Caused by Hereditary Protein C Deficiency.

82. Protein C Gene Mutation in an Older Adult Patient with Clostridium perfringens Septicemia-Related Visceral Vein Thrombosis.

83. Donor UNC-93 Homolog B1 genetic polymorphism predicts survival outcomes after unrelated bone marrow transplantation.

84. The Japanese Medical Science Federation COVID-19 Expert Opinion English Version.

85. Comparative evaluation of reagents for measuring protein S activity: possibility of harmonization.

86. COVID-19-Related Thrombosis in Japan: Final Report of a Questionnaire-Based Survey in 2020.

87. Evaluation of Optimal Sample Processing Conditions for Accurate Measurement of Protein S Activity.

88. [COVID-19-associated coagulopathy].

89. Recurrent Cerebral Venous Thrombosis Treated with Direct Oral Anticoagulants in a Japanese Man with Hereditary Protein C Deficiency.

90. Ilio-femoral venous thrombosis with hereditary antithrombin deficiency: a case report of rare thrombotic disease and successful treatment with catheter directed thrombolysis.

91. Evaluation of GENECUBE Mycoplasma for the detection of macrolide-resistant Mycoplasma pneumoniae .

92. Racial differences in protein S Tokushima and two protein C variants as genetic risk factors for venous thromboembolism.

93. Complete hemostasis achieved by factor XIII concentrate administration in a patient with bleeding after teeth extraction as a complication of aplastic anemia and chronic disseminated intravascular coagulation.

94. Molecular genetic analysis of inherited protein C deficiency caused by the novel large deletion across two exons of PROC.

95. Coagulation and fibrinolytic features in AL amyloidosis with abnormal bleeding and usefulness of tranexamic acid.

96. A Case of Ischemic Stroke With Congenital Protein C Deficiency and Carotid Web Successfully Treated by Anticoagulant and Carotid Stenting.

97. Donor Heme Oxygenase-1 Promoter Gene Polymorphism Predicts Survival after Unrelated Bone Marrow Transplantation for High-Risk Patients.

98. Hereditary Antithrombin Deficiency Presenting with Deep Venous Thrombosis During the Second Pregnancy.

99. Genetic analysis of a compound heterozygous patient with congenital factor X deficiency and regular replacement therapy with a prothrombin complex concentrate.

100. Potential therapeutics for antiphospholipid antibody associated thrombocytopenia: A systematic review and meta-analysis.

Catalog

Books, media, physical & digital resources